We have a tantalizing situation: on one hand, a mountain of animal evidence suggests this peptide could be a revolutionary healing therapy
GLP-1RAs, which are approved to treat type 2 diabetes, obesity, and obstructive sleep apnea, are now being investigated for their effects on processes involving appetite and satiety, reward processing, stress regulation, cognition, and neuroinflammation
AMPK then shuts down a pro-inflammatory complex called NFkB , reducing inflammation in the brain ( to the left of the middle AMPK )
Inoue T, Inoguchi T, Sonoda N, Hendarto H, Makimura H, Sasaki S, Yokomizo H, Fujimura Y, Miura D, Takayanagi R
Providers who wish to have a prescription filled by our pharmacy should submit a new prescription directly to our pharmacy
Combining GLP1-RAs/SGLT2is for glucose control could be more effective than other antidiabetic combinations